ULISSE BIOMED SPA (UBM.MI) Stock Price, Quote, News and Overview
BIT:UBM - Euronext Milan - IT0005451213 - Common Stock - Currency: EUR
UBM.MI Quote, Performance and Key Statistics
BIT:UBM (4/23/2025, 7:00:00 PM)
0.76
-0.01 (-1.3%)
The current stock price of UBM.MI is 0.76 EUR. In the past month the price decreased by -11.42%. In the past year, price decreased by -76.1%.
UBM.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.41 | 294.36B | ||
| 1ABBV.MI | ABBVIE INC | 18.65 | 294.00B | ||
| AMG.DE | AMGEN INC | 14.24 | 133.58B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.48 | 114.62B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 22.33 | 112.99B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1665.96 | 111.35B | ||
| ARGX.BR | ARGENX SE | 355.79 | 33.02B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 22.22B | ||
| IDP.DE | BIOGEN INC | 7.21 | 15.30B | ||
| 0QF.DE | MODERNA INC | N/A | 9.33B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.56B |
Related stock screener links
About UBM.MI
Company Profile
Ulisse BioMed SpA is an Italian healthcare biotech company. The company is headquartered in Udine, Udine. The company went IPO on 2021-08-06. The firm focuses on creating new and transformative diagntostic platforms and products. The company creates diagnostic systems that can reach people directly and help increasing the frequency of health monitoring. Its platforms include Sagitta, NanoHybrid and Aptavir. Sagitta is a molecular diagnostics technology platform, capable of detecting and characterizing nucleic acids of viral, bacterial and eukaryotic origin. Sagitta is used to develop assays for Respiratory Viral Panel, Sexually Transmitted Diseases, Infectious Diseases and Oncology. NanoHybrid can be implemented not only to develop diagnostic solutions but also in the field of theranostics: the integration of a diagnostic method with a specific therapeutic intervention aimed at maximizing the effectiveness of the drug, as well as vaccine/immunoterapies monitoring. Aptavir is a platform for the identification and production of antiviral molecules.
Company Info
ULISSE BIOMED SPA
Via Aquileia 17
Udine UDINE IT
Employees: 8
Company Website: https://ulissebiomed.com/
Investor Relations: https://www.ulissebiomed.com/it/investor-relations/
Phone: 390403757540
ULISSE BIOMED SPA / UBM.MI FAQ
What is the stock price of ULISSE BIOMED SPA today?
The current stock price of UBM.MI is 0.76 EUR. The price decreased by -1.3% in the last trading session.
What is the ticker symbol for ULISSE BIOMED SPA stock?
The exchange symbol of ULISSE BIOMED SPA is UBM and it is listed on the Euronext Milan exchange.
On which exchange is UBM.MI stock listed?
UBM.MI stock is listed on the Euronext Milan exchange.
What is the price forecast or stock price prediction for ULISSE BIOMED SPA stock?
null analysts have analysed UBM.MI and the average price target is 1 EUR. This implies a price increase of 31.53% is expected in the next year compared to the current price of 0.76. Check the ULISSE BIOMED SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ULISSE BIOMED SPA worth?
ULISSE BIOMED SPA (UBM.MI) has a market capitalization of 18.60M EUR. This makes UBM.MI a Nano Cap stock.
How many employees does ULISSE BIOMED SPA have?
ULISSE BIOMED SPA (UBM.MI) currently has 8 employees.
What are the support and resistance levels for ULISSE BIOMED SPA (UBM.MI) stock?
ULISSE BIOMED SPA (UBM.MI) has a resistance level at 0.77. Check the full technical report for a detailed analysis of UBM.MI support and resistance levels.
Should I buy ULISSE BIOMED SPA (UBM.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of UBM.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of UBM.MI, evaluating the profitability, health, valuation and growth aspects
- ULISSE BIOMED SPA (UBM.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ULISSE BIOMED SPA (UBM.MI) Sales and EPS estimates to see what analysts future expectations are.
- ULISSE BIOMED SPA (UBM.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ULISSE BIOMED SPA (UBM.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- ULISSE BIOMED SPA (UBM.MI) Stock Chart to make your own analysis
- ULISSE BIOMED SPA (UBM.MI) Latest news and press-releases to stay up to date.
Does ULISSE BIOMED SPA (UBM.MI) stock pay dividends?
UBM.MI does not pay a dividend.
What is the Price/Earnings (PE) ratio of ULISSE BIOMED SPA (UBM.MI)?
ULISSE BIOMED SPA (UBM.MI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.41).
UBM.MI Technical Analysis
UBM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to UBM.MI. UBM.MI may be in some trouble as it scores bad on both profitability and health.
UBM.MI Financial Highlights
Over the last trailing twelve months UBM.MI reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS decreased by -39.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.05% | ||
| ROE | -38.06% | ||
| Debt/Equity | 0.01 |